U.S. patent agency to review Harvard, MIT's claim to CRISPR technology | | The U.S. Patent and Trademark Office on Monday said it would review whether Harvard University and the Massachusetts Institute of Technology can claim rights to a gene-editing technology known as CRISPR, adding fuel to a rivalry between those institutions and the University of California. |
|
| | | | | | | | | | | | | | | | | | | | | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today | |
| | | | The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today | |
| | » » MORE NEWSLETTERS | |
|